Cancer Family
Soft Tissue Neoplasm
CI-CAN-00000354Explore in graph →
Non-malignant441 active trials9 approved drugs183 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000354Explore in graph →
Clinical trials
2,078 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01265030 | A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis | completed | Phase 1 / Phase 2 | 9 | MaineHealthOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT04874246 | Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy(VALENTINE) | completed | N/A | 39 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 |
| NCT01327885 | Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma | completed | Phase 3 | 452 | Eisai Inc.INDUSTRY | 23 | Jun 22, 2023 | clinicaltrials |
| NCT02367924 | Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma(YonSar) | completed | — | 130 | PharmaMar, SpainINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT03317457 | Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma(MEDISARC) | completed | Phase 2 | 103 | AIO-Studien-gGmbHOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT04177693 | Pharmacokinetics and Hepatic Safety of EGCG | completed | Phase 1 | 39 | Yale UniversityOTHER | 1 | Jun 5, 2023 | clinicaltrials |
| NCT04593758 | To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue | completed | Phase 1 / Phase 2 | 16 | Cornerstone PharmaceuticalsINDUSTRY | 1 | May 24, 2023 | clinicaltrials |
| NCT03452644 | US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors | completed | — | 350 | Istituto Ortopedico RizzoliOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT04991883 | Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities(MFS) | completed | — | 167 | Istituto Ortopedico RizzoliOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT03860376 | Ex Vivo Drug Sensitivity Testing and Mutation Profiling | completed | — | 25 | Florida International UniversityOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT04071574 | Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility(CS-EOSP-ICSI) | completed | Phase 1 / Phase 2 | 200 | Lebanese UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT03989661 | Is There a Place for Pre-operative Temporary Embolization of Uterine Fibroids(EMBOFIB) | completed | — | 119 | Fondation Hôpital Saint-JosephOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT04254939 | A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor | completed | Phase 1 / Phase 2 | 65 | CStone PharmaceuticalsINDUSTRY | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05813808 | Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas | completed | N/A | 50 | Helsinki University Central HospitalOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT03927651 | ICG to Assess Ovarian Perfusion | completed | Early Phase 1 | 54 | Northwestern UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05800106 | A Bioequivalence Study of Sunitinib Malate Capsules. | completed | Phase 1 | 24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 10, 2023 | clinicaltrials |
| NCT02494570 | A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa(AMPECT) | completed | Phase 2 | 34 | Aadi Bioscience, Inc.INDUSTRY | 1 | Apr 7, 2023 | clinicaltrials |
| NCT00716820 | Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan). | completed | — | 472 | PfizerINDUSTRY | 0 | Apr 6, 2023 | clinicaltrials |
| NCT05796700 | Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma | completed | N/A | 1,585 | Chinese PLA General HospitalOTHER | 0 | Apr 3, 2023 | clinicaltrials |
| NCT05323370 | Lymphangioleiomyomatosis, a Study on Cathepsin K(LAM-CAK) | completed | — | 19 | University Hospital, ToursOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT02066285 | Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma | completed | Phase 2 | 96 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT02638766 | Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST(REGISTRI) | completed | Phase 2 | 15 | Grupo Espanol de Investigacion en SarcomasOTHER | 3 | Mar 27, 2023 | clinicaltrials |
| NCT03459469 | Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 | completed | Phase 1 | 24 | Iterion TherapeuticsINDUSTRY | 2 | Mar 1, 2023 | clinicaltrials |
| NCT01949506 | (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas | completed | N/A | 9 | Medical College of WisconsinOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT03985449 | Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings(UPFRONT) | completed | N/A | 748 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04956198 | Drug Sensitivity and Mutation Profiling | completed | — | 14 | Florida International UniversityOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT04586751 | The Impact of Pecs Blocks on Postmastectomy Pain Syndrome | completed | N/A | 64 | Aretaieion University HospitalOTHER | 2 | Feb 8, 2023 | clinicaltrials |
| NCT01563783 | Post Market TRUST Study(TRUST) | completed | N/A | 84 | Acessa Health, Inc.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT03253913 | Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial(RESULT) | completed | Phase 2 | 25 | University of CincinnatiOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT00354835 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | completed | Phase 3 | 481 | Children's Oncology GroupNETWORK | 6 | Jan 31, 2023 | clinicaltrials |
| NCT04077515 | Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma | completed | Phase 4 | 92 | Children's Hospital of Fudan UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT03972917 | Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy | completed | — | 89 | University of Campania Luigi VanvitelliOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT02712112 | A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs | completed | Phase 2 | 51 | Asan Medical CenterOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT03609424 | PDR001 Plus Imatinib for Metastatic or Unresectable GIST | completed | Phase 1 / Phase 2 | 39 | Asan Medical CenterOTHER | 1 | Jan 3, 2023 | clinicaltrials |
| NCT05643339 | The Reproducibility of Microvascular Flow Imaging in Fibroids and Its Correlation With 2D and 3D Power Doppler Outcomes(MVF) | completed | — | 30 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05565066 | A Real-world Comparison of FNB and FNA in IHC-required Lesions. | completed | — | 439 | Huazhong University of Science and TechnologyOTHER | 1 | Dec 1, 2022 | clinicaltrials |
| NCT03353753 | Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies(INVICTUS) | completed | Phase 3 | 129 | Deciphera Pharmaceuticals, LLCINDUSTRY | 13 | Nov 21, 2022 | clinicaltrials |
| NCT00876031 | Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma(CWS-2007-HR) | completed | Phase 3 | 195 | University Hospital TuebingenOTHER | 5 | Nov 8, 2022 | clinicaltrials |
| NCT03590210 | Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas(NiTraSarc) | completed | Phase 2 | 92 | University Medicine GreifswaldOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT04952896 | Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease | completed | — | 350 | Peking University Third HospitalOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT01495598 | Pomalidomide for Kaposi Sarcoma in People With or Without HIV | completed | Phase 1 / Phase 2 | 28 | National Cancer Institute (NCI)NIH | 1 | Nov 1, 2022 | clinicaltrials |
| NCT00623831 | A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen | completed | Phase 1 | 17 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT02620748 | Use of Intravenous Tranexamic Acid During Myomectomy(TA) | completed | Phase 1 | 60 | George Washington UniversityOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT01389050 | High Precision RT For Soft-Tissue Sarcoma | completed | Phase 2 | 26 | University Health Network, TorontoOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT03465722 | (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST | completed | Phase 3 | 476 | Blueprint Medicines CorporationINDUSTRY | 18 | Oct 6, 2022 | clinicaltrials |
| NCT03062943 | A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)(LAM) | completed | Phase 2 | 30 | IRCCS MultimedicaOTHER | 1 | Sep 28, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Jun 26, 2023source: clinicaltrials